Abstract
Aim
The objective of this study was to investigate seasonal malaria chemoprevention (SMC) coverage during the 2018 campaign and to identify factors associated with full coverage (receiving three doses of SMC four times during a campaign) of children aged 3 to 59 months.
Subject and methods
This was a cross-sectional study conducted in nine regions of Burkina Faso. In each region, we purposely selected districts based on the epidemiological profile and randomly selected villages within each district. The World Health Organization (WHO) Expanded Programme on Immunization (EPI) method was used in the household selection process. A generalized linear mixed model (GLMM) was used to account for the hierarchical structure of the design and to identify factors associated with full SMC coverage.
Results
Our results showed that community distributors (CDs) visited more than 98% of the selected households, and 95.9% of the children received three doses of SMC in the last round in October 2018. Furthermore, 84.8% of children were fully covered after having received all three doses of SMC during four campaigns by the end of 2018. The age of the children and the occupation of the respondent were factors significantly associated with complete SMC coverage.
Conclusion
Full coverage of SMC among children aged 3 to 59 months remained below the expected coverage by the Burkina Faso Ministry of Health. It will be up to the Ministry of Health to strengthen the system for monitoring SMC activities.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author upon request.
Code availability
Code for data cleaning and analysis is available from the corresponding author upon request.
Abbreviations
- SMC :
-
Seasonal malaria chemoprevention
- WHO :
-
World Health Organization
- CBD :
-
Community-based distributor
- CD :
-
Community distributor
- CSPS :
-
Centre de Santé et de Promotion Social
- GLMM :
-
Generalized linear mixed model
- SP :
-
Sulfadoxine-pyrimethamine
- AQ :
-
Amodiaquine
- CBHW :
-
Community-based health workers
- UNICEF :
-
United Nations Children's Fund
References
Ba EH, Pitt C, Dial Y, Faye SL, Cairns M, Faye E, Ndiaye M, Gomis JF, Faye B, Ndiaye JL, Sokhna C, Gaye O, Cisse B, Milligan P (2018) Implementation, coverage and equity of large-scale door-to-door delivery of Seasonal Malaria Chemoprevention (SMC) to children under 10 in Senegal. Sci Rep 8:5489. http://www.ncbi.nlm.nih.gov/pubmed/29615763
Bakai TA, Thomas A, Iwaz J, Atcha-Oubou T, Tchadjobo T, Khanafer N, Rabilloud M, Voirin N (2022) Effectiveness of seasonal malaria chemoprevention in three regions of Togo: a population-based longitudinal study from 2013 to 2020. Malar J 21:400
Barry A, Issiaka D, Traore T, Mahamar A, Diarra B, Sagara I, Kone D, Doumbo OK, Duffy P, Fried M, Dicko A (2018) Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: A cluster randomized trial. PLoS One 13:e0193296. https://doi.org/10.1371/journal.pone.0193296
Bicaba A, Serme L, Chetaille G, Kombate G, Bila A, Haddad S (2020) Longitudinal analysis of the capacities of community health workers mobilized for seasonal malaria chemoprevention in Burkina Faso. Malar J 19:118. https://doi.org/10.1186/s12936-020-03191-y
Bojang KA, Akor F, Conteh L, Webb E, Bittaye O, Conway DJ, Jasseh M, Wiseman V, Milligan PJ, Greenwood B (2011) Two strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: a randomised controlled trial. PLoS Med 8:e1000409. http://www.ncbi.nlm.nih.gov/pubmed/21304921
Cairns M, Ceesay SJ, Sagara I, Zongo I, Kessely H, Gamougam K, Diallo A, Ogboi JS, Moroso D, Van Hulle S, Eloike T, Snell P, Scott S, Merle C, Bojang K, Ouedraogo JB, Dicko A, Ndiaye JL, Milligan P (2021) Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case-control studies in 5 countries. PLoS Med 18:e1003727. https://doi.org/10.1371/journal.pmed.1003727
Chatio S, Ansah NA, Awuni DA, Oduro A, Ansah PO (2019) Community acceptability of Seasonal Malaria Chemoprevention of morbidity and mortality in young children: A qualitative study in the Upper West Region of Ghana. PLoS One 14:e0216486. http://www.ncbi.nlm.nih.gov/pubmed/31100072
Compaore R, Yameogo MWE, Millogo T, Tougri H, Kouanda S (2017) Evaluation of the implementation fidelity of the seasonal malaria chemoprevention intervention in Kaya health district, Burkina Faso. PLoS One 12:e0187460. https://doi.org/10.1371/journal.pone.0187460
Dane AV, Schneider BH (1998) Program integrity in primary and early secondary prevention: are implementation effects out of control? Clin Psychol Rev 18:23–45. https://doi.org/10.1016/S0272-7358(97)00043-3
De Cola MA, Sawadogo B, Richardson S, Ibinaiye T, Traoré A, Compaoré CS, Oguoma C, Oresanya O, Tougri G, Rassi C, Roca-Feltrer A, Walker P, Okell LC (2022) Impact of seasonal malaria chemoprevention on prevalence of malaria infection in malaria indicator surveys in Burkina Faso and Nigeria. BMJ Glob Health 7, e008021. https://gh.bmj.com/content/bmjgh/7/5/e008021.full.pdf
DHS (2017) Burkina Faso: Malaria indicator survey (MIS). URL https://dhsprogram.com/methodology/survey/survey-display-526.cfm. Accessed 06 April 2023
Diawara F, Steinhardt LC, Mahamar A, Traore T, Kone DT, Diawara H, Kamate B, Kone D, Diallo M, Sadou A, Mihigo J, Sagara I, Djimde AA, Eckert E, Dicko A (2017) Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali. Malar J 16:325. http://www.ncbi.nlm.nih.gov/pubmed/28797263
Diawara SI, Konaté D, Kayentao K, Mihigo J, Shaffer JG, Sangare M, Ndabamenye P, Swedberg E, Garg LW, Gamache N, Keita B, Kamate B, Ndaruhutse P, Kone D, Sanogo V, Tounkara M, Diakité M, Doumbia S, Eckert E (2022) Effect of seasonal malaria chemoprevention in children between 5 and 9 years old in Kita and Bafoulabe districts, Mali. Parasite Epidemiol Control 18:e00258. https://doi.org/10.1016/j.parepi.2022.e00258
Druetz T, Corneau-Tremblay N, Millogo T, Kouanda S, Ly A, Bicaba A, Haddad S (2018) Impact Evaluation of Seasonal Malaria Chemoprevention under Routine Program Implementation: A Quasi-Experimental Study in Burkina Faso. Am J Trop Med Hyg 98:524–533. https://doi.org/10.4269/ajtmh.17-0599
Dusenbury L, Brannigan R, Falco M, Hansen WB (2003) A review of research on fidelity of implementation: implications for drug abuse prevention in school settings. Health Educ Res 18:237–56. https://doi-org.acces.bibl.ulaval.ca/https://doi.org/10.1093/her/18.2.237
Kirakoya-Samadoulougou F, De Brouwere V, Fokam AF, Ouédraogo M, Yé Y (2022) Assessing the effect of seasonal malaria chemoprevention on malaria burden among children under 5 years in Burkina Faso. Malar J 21:143
Koko DC, Maazou A, Jackou H, Eddis C (2022) Analysis of attitudes and practices influencing adherence to seasonal malaria chemoprevention in children under 5 years of age in the Dosso Region of Niger. Malar J 21:375. https://doi.org/10.1186/s12936-022-04407-z
Konaté D, Diawara SI, Keita B, Sogoba N, Fayiçal M, Guindo A, Thiam S, Traoré SF, Shaffer JG, Doumbia S, Diakité M (2021) Effectiveness and Community Acceptance of Extending Seasonal Malaria Chemoprevention to Children 5 to 14 Years of Age in Dangassa, Mali. Am J Trop Med Hyg 106:648–654. https://doi.org/10.4269/ajtmh.21-0046
Konate D, Diawara SI, Sogoba N, Shaffer J, Keita B, Cisse A, Sanogo I, Dicko I, Guindo MDA, Balam S, Traore A, Kante S, Dembele A, Kasse F, Denou L, Diakite SAS, Traore K, M'Baye Thiam S, Sanogo V, Toure M, Diarra A, Agak GW, Doumbia S, Diakite M (2023) Effect of a fifth round of seasonal malaria chemoprevention in children aged 5–14 years in Dangassa, an area of long transmission in Mali. Parasite Epidemiol Control 20:e00283. https://doi.org/10.1016/j.parepi.2022.e00283
Manga IA, Tairou F, Seck A, Kouevidjin E, Sylla K, Sow D, Gueye AB, Ba M, Ndiaye M, Tine RCK, Gaye O, Faye B, Ndiaye JLA (2022) Effectiveness of seasonal malaria chemoprevention administered in a mass campaign in the Kedougou region of Senegal in 2016: a case-control study. Wellcome Open Res 7:216. https://doi.org/10.12688/wellcomeopenres.18057.3
Nadimpalli V HK (2012) Simplifying the analysis of complex survey data using the SAS survey analysis procedures. SAS Global Forum 2012;Paper 348–2012. https://support.sas.com/resources/papers/proceedings12/348-2012.pdf
NDiaye JL, Cisse B, Ba EH, Gomis JF, Ndour CT, Molez JF, Fall FB, Sokhna C, Faye B, Kouevijdin E, Niane FK, Cairns M, Trape JF, Rogier C, Gaye O, Greenwood BM, Milligan PJ (2016) Safety of Seasonal Malaria Chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine when Delivered to Children under 10 Years of Age by District Health Services in Senegal: Results from a Stepped-Wedge Cluster Randomized Trial. PLoS One 11:e0162563. http://www.ncbi.nlm.nih.gov/pubmed/27764102
Ndiaye JA, Diallo I, Y ND, Kouevidjin E, Aw I, Tairou F, Ndoye T, Halleux CM, Manga I, Dieme MN, Ndiop M, Faye B, Olliaro P, Merle CS, Gaye O, Milligan P (2018) Evaluation of Two Strategies for Community-Based Safety Monitoring during Seasonal Malaria Chemoprevention Campaigns in Senegal, Compared with the National Spontaneous Reporting System. Pharmaceut Med 32:189–200. http://www.ncbi.nlm.nih.gov/pubmed/29983573
Okereke E, Smith H, Oguoma C, Oresanya O, Maxwell K, Anikwe C, Osuji LC, Ogazi O, Musa J, Rajab A, Shekarau E, Okoh F, Viganò E, Donovan L, Ward C, Baker K (2023) Optimizing the role of “lead mothers” in seasonal malaria chemoprevention (SMC) campaigns: formative research in Kano State, northern Nigeria. Malar J 22:13. https://doi.org/10.1186/s12936-023-04447-z
OMS (2018) Lancement de la campagne 2018 de chimio prévention du paludisme saisonnier. URL https://www.afro.who.int/fr/news/lutte-contre-le-paludisme-au-burkina-faso-lancement-de-la-campagne-2018-de-chimio-prevention. Accessed 22 Jul 2022
Partnership A-S (2020) Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study. Lancet 396:1829–1840. https://doi.org/10.1016/S0140-6736(20)32227-3
Reiner RC Jr, Hay SI (2022) The overlapping burden of the three leading causes of disability and death in sub-Saharan African children. Nat Commun 13:7457. https://doi.org/10.1038/s41467-022-34240-6
Sacko A, Sagara I, Berthé I, Diarra M, Cissoko M, Diarra SS, Coulibaly D, Sanogo M, Dicko A (2021) Evolution of Malaria Incidence in Five Health Districts, in the Context of the Scaling Up of Seasonal Malaria Chemoprevention, 2016 to 2018, in Mali. Int J Environ Res Public Health 18. https://doi.org/10.3390/ijerph18020840
Slaughter SE, Hill JN, Snelgrove-Clarke E (2015) What is the extent and quality of documentation and reporting of fidelity to implementation strategies: a scoping review. Implement Sci 10:129
Sokhna C, Cisse B, Ba el H, Milligan P, Hallett R, Sutherland C, Gaye O, Boulanger D, Simondon K, Simondon F, Targett G, Lines J, Greenwood B, Trape JF (2008) A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children. PLoS One 3:e1471. http://www.ncbi.nlm.nih.gov/pubmed/18213379
WHO (2008) Training for mid-level managers (MLM). Module 7: the EPI coverage survey. https://creativecommons.org/licenses/by-nc-sa/3.0/igo. Accessed 17 Aug 2020
WHO (2013) Seasonal Malaria Chemoprevention with sulfadoxine–pyrimethamine plus amodiaquine in children: a field guide. https://apps.who.int/iris/handle/10665/85726. Accessed 14 May 2023
WHO (2015) World malaria report 2015. https://apps.who.int/iris/handle/10665/200018. Accessed 14 May 2023
WHO (2022) World malaria report 2022. https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2022. Accessed 06 Apr 2023
Acknowledgements
We would like to thank our colleague for reviewing this English version of the manuscript. We would like also to thank the Ministry of the Health of Burkina Faso, The Programme National de Lutte contre le Paludisme (PNLP), and the mothers or guardians of children.
Funding
This study was supported by the World Bank and WHO.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Antarou Ly. The first draft of the manuscript was written by Antarou Ly, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The study was approved by the Burkina Faso Health Research Ethics Committee (no. 2019-3-031). As our target population was children under 5 years of age, consent was obtained from the children's mothers or guardians. Particular care was taken to respect the norms of confidentiality and nondisclosure of the participants' identities. The project staff signed a confidentiality and good ethical practice agreement.
Consent for publication
Not applicable.
Competing interests
All authors declare no competing interests associated with this manuscript.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ly, A., Lanou, H.B., Moyenga, L. et al. Coverage of seasonal malaria chemoprevention in children aged 3 to 59 months in Burkina Faso: a nationwide cross-sectional study. J Public Health (Berl.) (2023). https://doi.org/10.1007/s10389-023-02036-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10389-023-02036-7